MAC
47
-7
TRIP
60
-6
SHW
53
5
TGNA
58
-3
VNO
61
2
EQR
44
8
AES
55
-3
AMG
55
-3
FMC
37
-3
MAT
65
-2
VRSK
70
4
ALLE
50
4
AVB
52
2
SJM
26
5
STZ
38
4
NVDA
71
-4
EQIX
74
9
WMB
62
4
ZTS
33
6
MMM
68
2
MAC
47
-7
TRIP
60
-6
SHW
53
5
TGNA
58
-3
VNO
61
2
EQR
44
8
AES
55
-3
AMG
55
-3
FMC
37
-3
MAT
65
-2
VRSK
70
4
ALLE
50
4
AVB
52
2
SJM
26
5
STZ
38
4
NVDA
71
-4
EQIX
74
9
WMB
62
4
ZTS
33
6
MMM
68
2
Financhill
Back

Editas Medicine 10K Form

Sell
21

EDIT
Editas Medicine

Last Price:
$1.40
Seasonality Move:
7.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EDIT News And Ratings

See the #1 stock for the next 7 days that we like better than EDIT

EDIT Financial Statistics

Sales & Book Value

Annual Sales: $32.3M
Cash Flow: $-47.9M
Price / Cash Flow: 0
Annual Sales: $0.75
Price / Book: 1.87

Profitability

EPS (TTM): -3.04000
Net Income (TTM): $-251.2M
Gross Margin: --
Return on Equity: -139.77%
Return on Assets: -71.46%

Editas Medicine Earnings Forecast

Key Editas Medicine Financial Ratios

  • The Research & Development expenses have been 616.60% of Revenue.
  • The Net Earning history of EDIT is -733.72% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Editas Medicine Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EDIT
CUSIP: 28106W
Website: editasmedicine.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.08
Quick Ratio: 3.03

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EDIT Technical Analysis vs Fundamental Analysis

Sell
21
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy or a Sell?

  • Editas Medicine stock is rated a Sell
    The current Editas Medicine [EDIT] share price is $1.40. The Score for EDIT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.